Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2010
11/18/2010WO2010131475A1 NOVEL STABLE CRYSTAL OF 1-(2'-CYANO-2'-DEOXY-β-D-ARABINOFURANOSYL)CYTOSINE MONOHYDROCHLORIDE
11/18/2010WO2010131460A1 Anti-tumor agent comprising tegafur-gimeracil-oteracil potassium combination drug and oxaliplatin
11/18/2010WO2010131265A1 Novel pharmaceutical compositions of choline fenofibrate
11/18/2010WO2010131191A1 Thiazolidin-4-one and [1,3]-thiazinan-4-one compounds as orexin receptor antagonists
11/18/2010WO2010131175A1 Process for preparing a crosslinked gel
11/18/2010WO2010131147A1 Cyclobutenedione derivatives
11/18/2010WO2010131146A1 Cyclobutenedione derivatives
11/18/2010WO2010131145A1 Cyclobutenedione derivatives
11/18/2010WO2010131118A2 Polymorphs of etravirine and processes for preparation thereof
11/18/2010WO2010131116A2 Use of lipid conjugates in the treatment of diseases associated with vasculature
11/18/2010WO2010131092A1 Process for the preparation of sevelamer
11/18/2010WO2010131038A2 Steroid containing composition and uses thereof
11/18/2010WO2010131035A1 Novel crystalline polymorph of sitagliptin dihydrogen phosphate
11/18/2010WO2010131033A1 Perhexiline for use in the treatment of hypertrophic cardiomyopathy (hcm)
11/18/2010WO2010131025A1 Sitagliptin synthesis
11/18/2010WO2010131022A1 [1,2,4] triazolo [4,3-b] pyridazines as ligands of the androgen receptor
11/18/2010WO2010130983A1 A method and composition for the control of ectoparasites
11/18/2010WO2010130982A2 Composition
11/18/2010WO2010130977A1 Methods of chemical synthesis of diaminophenothiazinium compounds involving the use of persulfate oxidants
11/18/2010WO2010130945A1 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130944A1 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130943A1 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130934A2 2-cycloamino-5-(pyridin-4-yl)imidazo[2,1-b][1,3,4]thiadiazole derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130900A2 Triaminopyrimidine derivatives as cdc25 phosphatase inhibitors
11/18/2010WO2010130896A2 Method for admixing the lipopolysaccharide (lps) of gram-negative bacteria
11/18/2010WO2010130842A1 Thieno [2, 3-b] pyridine derivatives as viral replication inhibitors
11/18/2010WO2010130799A2 Method for impregnation with supercritical co2
11/18/2010WO2010130796A1 Aryl pyridine as aldosterone synthase inhibitors
11/18/2010WO2010130794A1 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
11/18/2010WO2010130779A2 COMBINATION OF A PBOSPBOINOSITKLE 3-KSπASE INHIBITOR AND AN ANTIDIABETIC COMPOUND
11/18/2010WO2010130768A1 Novel 1,4-diaza-bicyclo[3.2.1]octane derivatives useful as nicotinic acetylcholine receptor modulators
11/18/2010WO2010130758A1 New combination therapy in treatment of cancer and fibrotic diseases
11/18/2010WO2010130757A1 New combination therapy in treatment of oncological and fibrotic diseases
11/18/2010WO2010130751A1 Humanized axl antibodies
11/18/2010WO2010130726A1 Uracyl spirooxetane nucleosides
11/18/2010WO2010130702A1 Infant and young children feeding formula comprising probiotics for infants and young children
11/18/2010WO2010130672A1 Azabicyclo [4.1.0] heptane derivatives and their use as monoamine reuptake inhibitors
11/18/2010WO2010130665A1 Azacyclic spiroderivatives as hsl inhibitors
11/18/2010WO2010130638A1 Sulfonamide compounds, pharmaceutical compositions and uses thereof
11/18/2010WO2010130620A1 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/18/2010WO2010130468A1 New medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity
11/18/2010WO2010130466A1 Sulphated hyaluronic acids as regulator agents of the cytokine activity
11/18/2010WO2010130462A2 Phosphate-free pharmaceutical composition for the treatment of glaucoma
11/18/2010WO2010130460A1 Amorphous silibinin for the treatment of viral hepatitis
11/18/2010WO2010130435A1 Oil-in-water emulsion of mometasone
11/18/2010WO2010130428A1 Oil-in-water emulsion of mometasone and propylene glycol
11/18/2010WO2010130424A1 1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
11/18/2010WO2010130423A1 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
11/18/2010WO2010130422A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
11/18/2010WO2010130393A2 Orodispersible tablet containing a vardenafil salt
11/18/2010WO2010130392A1 Desfesoterodine in the form of a tartaric acid salt
11/18/2010WO2010130351A1 Micrornas as biomarkers and therapeutic targets for heart failure
11/18/2010WO2010130233A1 Substituted 6-(benzylamino) purine riboside derivatives, use thereof and compositions containing these derivatives
11/18/2010WO2010130224A1 Thiophene derivatives
11/18/2010WO2010130178A1 Acrylamide derivative and use thereof in manufacture of medicament
11/18/2010WO2010130152A1 Pharmaceutical composition for treating cardiovascular disorder and use thereof
11/18/2010WO2010130147A1 Pyronaridine lactate, pharmaceutical composition and use thereof
11/18/2010WO2010130139A1 Ascorbic acid aryl acetate/propionate ester, preparation method and pharmaceutical composition thereof
11/18/2010WO2010130063A1 The little molecule compound which used for promoting the stem cells hyperplasia and the use thereof
11/18/2010WO2010130036A1 Stable functional beverage compositions and processes for making same
11/18/2010WO2010130034A1 Inhibitors of human immunodeficiency virus replication
11/18/2010WO2010130028A1 Compositions suitable for the topical treatment of fungal infections of the skin and nails
11/18/2010WO2010117323A8 Isoxazol-3(2h)-one analogs as therapeutic agents
11/18/2010WO2010111719A3 Melanogenesis inhibition by 3, 5-dimethoxy-4'-hydroxystilbenes and cosmeceutical compositions thereof
11/18/2010WO2010111712A3 Identification of rnai targets and use of rnai for rational therapy of chemotherapy-resistant leukemia and other cancers
11/18/2010WO2010111650A3 Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
11/18/2010WO2010111640A3 Anti-influenza formulations and methods
11/18/2010WO2010111626A3 Poly (adp-ribose) polymerase (parp) inhibitors
11/18/2010WO2010111468A3 RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
11/18/2010WO2010109434A3 A medicinal antibacterial, antifungal and steroids cream comprising chitosan and a process to make it
11/18/2010WO2010107791A3 Pyrazinoisoquinoline compounds
11/18/2010WO2010107177A3 Composition for prevention or treatment of obesity, dyslipidemia, fatty liver or insulin resistance syndrome comprising camphene as active ingredients
11/18/2010WO2010106571A3 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids
11/18/2010WO2010106457A3 3-oxa-7-azabicyclo[3.3.1]nonanes
11/18/2010WO2010103297A3 Bis aromatic compounds for use as ltc4 synthase inhibitors
11/18/2010WO2010102154A3 Biaryl oxyacetic acid compounds
11/18/2010WO2010100133A3 Indole derivatives for treating neurodegenerative diseases
11/18/2010WO2010097501A3 A combination treatment of stroke
11/18/2010WO2010089763A3 Poly(n-vinyl caprolactam-co-acrylamide) microparticles for controlled release applications
11/18/2010WO2010088866A3 Novel saponin compounds, methods of preparation thereof, use thereof and pharmaceutical compositions
11/18/2010WO2010085799A9 Compositions and method for the treatment of parkinson's disease
11/18/2010WO2010083280A3 Methods for treating obesity and disorders associated with hyperlipidemia in a mammal
11/18/2010WO2010083279A3 Methods for treating disorders associated with hyperlipidemia in a mammal
11/18/2010WO2010083104A3 Conjugates of noscapine and folic acid and their use in treating cancer
11/18/2010WO2010082789A3 Anticancer compositions comprising cedrol in nanoparticle form
11/18/2010WO2010080603A9 Method of treatment of aggression
11/18/2010WO2010076564A3 Isochromenones useful in the treatment of inflammation
11/18/2010WO2010075423A3 Dendrimer based modular platforms
11/18/2010WO2010071866A3 Combination therapy for arthritis with tranilast
11/18/2010WO2010071846A3 Compounds for treating neuropsychiatric conditions
11/18/2010WO2010069605A3 Oxidized cardiolipin as a novel pro-inflammatory factor
11/18/2010WO2010067078A3 3,6-disubstituted xanthylium salts as medicaments
11/18/2010WO2010065879A9 Methods of treating an overweight or obese subject
11/18/2010WO2010065586A3 Preparation of capecitabine
11/18/2010WO2010065567A3 Methods and compositions for altering health, wellbeing, and lifespan
11/18/2010WO2010059719A3 Dimeric 1-arylpyrazole derivatives
11/18/2010WO2010059611A3 Inhibitors of diacylglycerol acyltransferase
11/18/2010WO2010056644A8 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
11/18/2010WO2010049952A3 A novel process for the preparation of eletriptan
11/18/2010WO2010045251A3 Spiro-oxindole compounds and their use as therapeutic agents
1 ... 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 ... 7860